PSYC 211- Midterm 1 Review

During the day i let less through what am i a lens b

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: disease 4)  L- DOPA is given to treat Parkinson’s pa1ents 5)  Parkinson’s pa1ents have trouble ini1a1ng movements Dopaminergic Pathway Mesolimbic pathway reward Ventral tegmental area à༎ limbic system Mesocor4cal pathway Short term memory VTA à༎ PFC prefrontal cortex Nigrostriatal pathway movement Substan1a nigra à༎ neostriatum Disorder: Parkinson’s Dopamine neuromodulators: which have agonis1c proper1es, which have antagonis1c proper1es 1)  2)  3)  4)  5)  6)  alpha- methyl para tyrosine: prevents DA synthesis Reserpine: prevents vesicular storage of DA Cocaine: blocks DA transporter Amphetamine: blocks and reverses DA transporters Apomorphine: binds to and ac1vates D2 receptors Chlorpromazine: binds to and inac1vates D2 receptors 7)  Monoamine oxidase: enzyme that degrades DA in the terminal buaon Dopamine neuromodulators: which have agonis1c proper1es, which have antagonis1c proper1es? 1)  alpha- methyl para tyrosine: prevents DA synthesis ANTAGONIST 2)  Reserpine: prevents vesicular storage of DA ANTAGONIST 3)  Cocaine: blocks DA transporter AGONIST 4)  Amphetamine: blocks and reverses DA transporters AGONIST 5)  Apomorphine: binds to and ac1vates D2 receptors DIRECT AGONIST 6)  Chlorpromazine: binds to and inac1vates D2 receptors DIRECT ANTAGONIST 7)  Monoamine oxidase: enzyme that degrades DA in the terminal buaon ANTAGONIST Ques1ons on Chapter 4? Chapter 5: Research Methods Which of the following abla1on techniques would be used to destroy neural cell bodies, axons and astrocytes? 1)  Radio frequency lesion 2)  Excitotoxic lesion 3)  Lesion by co...
View Full Document

Ask a homework question - tutors are online